首页> 外文期刊>International braz j urol >HRQOL related to urinary diversion in Radical Cystectomy: a systematic review of recent literature
【24h】

HRQOL related to urinary diversion in Radical Cystectomy: a systematic review of recent literature

机译:HRQOL与根治性膀胱切除术中尿流转移有关:近期文献的系统评价

获取原文
       

摘要

ABSTRACT Introduction: The health-related QoL is a patient-centered evaluation covering several aspects. This evaluation seems to be particularly important in patients submitted to radical cystectomy (RC) and urinary diversion with ileal conduit (IC) or a neobladder (NB). Objective: Review all recent data comparing QoL outcomes after radical cystectomy with NB and IC diversions. Evidence Acquisition: A systematic search in PubMed/Medline, Embase, and Cochrane databases was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) statement in December 2018. All articles published from January 01, 2012 to December 31, 2018, were included. A study was considered relevant if it compared QoL outcomes using validated questionnaires (EORTC QLQ C30, FACT-G, FACT-BL, FACT-VCI, and BCI). Evidence Synthesis: In 11 included studies, a total of 1389 participants were accounted (730 NB and 659 IC cases). The studies were conducted in 8 different countries, two were prospective, and none was randomized. There were two studies favoring results with a neobladder, 3 with incontinent diversion and 6 with no differences. The EORTC-QLQ-C30 was the most used instrument (5 studies) followed by FACT VCI and BCI (3 studies each). Given the heterogeneity of data and lack of prospective studies, a meta-analysis was not performed. Conclusion: No superiority of one urinary diversion was characterized. It seems that the choice must be individualized with an extensive preoperative orientation of the patient and their relatives. That will probably influence how the patient accepts the new condition.
机译:摘要简介:与健康相关的QoL是一项以患者为中心的评估,涵盖多个方面。对于接受根治性膀胱切除术(RC)和回肠导管(IC)或新膀胱(NB)进行尿流改道的患者,这种评估似乎特别重要。目的:回顾所有比较根治性膀胱切除术后NB和IC转移的QoL结局的最新数据。证据获取:根据2018年12月系统评价和荟萃分析的首选报告项目(PRISMA)声明,对PubMed / Medline,Embase和Cochrane数据库进行了系统搜索。所有文章于2012年1月1日至12月31日发表。 ,2018年。如果一项研究使用经过验证的问卷(EORTC QLQ C30,FACT-G,FACT-BL,FACT-VCI和BCI)比较了QoL结果,则认为该研究是相关的。证据综合:在11项纳入研究中,共计1389名参与者(730 NB和659例IC病例)。研究在8个不同的国家进行,其中两个是前瞻性的,没有一个是随机的。有两项研究倾向于使用新膀胱的结果,其中3项涉及失禁转移,6项没有差异。 EORTC-QLQ-C30是使用最多的仪器(5个研究),其次是FACT VCI和BCI(每个3个研究)。鉴于数据的异质性和缺乏前瞻性研究,未进行荟萃分析。结论:没有一种尿分流的优势。似乎必须根据患者及其亲属的广泛术前取向来进行个性化选择。这可能会影响患者接受新疾病的方式。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号